NovaBay Pharmaceuticals, Inc. (NBY) stock has fallen -37.39% over the last 12 months. InvestorsObserver’s proprietary ranking system, gives NBY stock a score of 4 out of a possible 100.
That rank is influenced by a fundamental score of 0. NBY stock has a mean target price of $1.90. This means analysts expect the stock to gain 163.89% over the next 12 months. NBY's rank also includes a short-term technical score of 2. The long-term technical score for NBY is 11.
NBY has an Overall Score of 4. Find out what this means to you and get the rest of the rankings on NBY!
NovaBay Pharmaceuticals, Inc. (NBY) stock is up 16.21% while the S&P 500 has fallen -0.98% as of 1:55 PM on Tuesday, Jul 27. NBY is up $0.10 from the previous closing price of $0.62 on volume of 15,578,263 shares. Over the past year the S&P 500 has risen 35.18% while NBY has fallen -37.39%. NBY lost -$0.31 per share in the over the last 12 months.
Click Here to get the full Stock Report for NovaBay Pharmaceuticals, Inc. stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
